Trade Vir Biotechnology VIR

Sell
 Buy

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

instrument_fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) instr__open High Low

instr__news

Webhose 2025 Jun 04, 00:39

Insider Selling: Vir Biotechnology, Inc. (NASDAQ:VIR) Director Sells 3,200 Shares of Stock

Vir Biotechnology Inc
Webhose 2025 Jun 03, 07:38

Nuveen Asset Management LLC Has $2.64 Million Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Jun 02, 00:00

Vir Biotechnology Inc. (VIR) - Insider Monkey

Vir Biotechnology Inc
Webhose 2025 May 31, 16:48

Vir Biotechnology (NASDAQ:VIR) Stock Price Down 7.6% - Here's What Happened

Vir Biotechnology Inc
Webhose 2025 May 30, 18:08

Vir Biotechnology (NASDAQ:VIR) Trading 6.6% Higher - What's Next?

Vir Biotechnology Inc
Webhose 2025 May 27, 00:00

Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections

Vir Biotechnology Inc
Webhose 2025 May 24, 12:10

Vir Biotechnology's (VIR) Buy Rating Reaffirmed at Needham & Company LLC

Vir Biotechnology Inc
Webhose 2025 May 22, 08:42

Point72 Asset Management L.P. Raises Stock Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 May 20, 21:26

Company Website: https://vir.bio SAN FRANCISCO -- (Busines

Vir Biotechnology Inc
Webhose 2025 May 20, 11:02

Stonepine Capital Management LLC Takes Position in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 May 15, 11:52

Orbimed Advisors LLC Reduces Stock Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 May 15, 09:25

Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Acquired by Hudson Bay Capital Management LP

Vir Biotechnology Inc
Webhose 2025 May 12, 14:30

Vir Biotechnology (VIR) Maintains 'Buy' Rating as Price Target Adjusted | VIR Stock News

Vir Biotechnology Inc
Webhose 2025 May 11, 13:34

Earnings Update: Vir Biotechnology, Inc. (NASDAQ:VIR) Just Reported And Analysts Are Trimming Their Forecasts

Vir Biotechnology Inc
Webhose 2025 May 11, 10:38

Vir Biotechnology (NASDAQ:VIR) Trading Down 5.5% - Here's What Happened

Vir Biotechnology Inc
Webhose 2025 May 11, 07:51

Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Purchased by Dimensional Fund Advisors LP

Vir Biotechnology Inc
Webhose 2025 May 09, 12:15

Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2025 Earnings Call Transcript

Vir Biotechnology Inc
Webhose 2025 May 09, 10:42

Vir Biotechnology (VIR) Unveils Promising Hepatitis B Treatment Data | VIR Stock News

Vir Biotechnology Inc
Webhose 2025 May 09, 10:00

Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study | Morningstar

Vir Biotechnology Inc
Webhose 2025 May 08, 07:31

Vir Biotechnology Inc (VIR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...

Vir Biotechnology Inc
Webhose 2025 May 08, 05:13

Q1 2025 Vir Biotechnology Inc Earnings Call Transcript

Vir Biotechnology Inc

VirBiotechnology news

Latest news

Show more
Ghko B 2025 Jun 05, 16:00

Trump-Musk Relationship Collapses: Tesla Stock Drops 10%

Stocks
Ghko B 2025 Jun 04, 16:00

SOFI Stock Analysis: What is the 5-year forecast for SoFi?

Stocks
Ghko B 2025 Jun 04, 16:00

VOO Performance Analysis: Is Vanguard S&P 500 ETF good to invest in?

ETFs
Ghko B 2025 Jun 04, 16:00

Intel Stock Is Trending Now: What to Know about Intel Corporation (INTC)?

Stocks
Tommy Yap 2025 Jun 04, 16:00

Morning Note: ECB Rate Cut Expected; Canada PMI in Focus; EUR/USD, USD/CAD

Morning Note Forex CAD
Tommy Yap 2025 Jun 04, 16:00

Morning Note: ECB Rate Cut Expected; Broadcom Earnings; Oil Falls on Supply

Morning Note Tech Commodities
Frances Wang 2025 Jun 03, 16:00

AI Stock Analysis: PLTR Hits Record High as Government Deals Fuel Momentum

Stocks
Frances Wang 2025 Jun 03, 16:00

ACHR Stock Analysis: What’s Driving Archer Aviation's Market Performance?

Stocks

Info

Spread

0.05

Spread (%)

0.9690 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

729896640

instr__shares_outstand

138238000

instr__earnings_date

0000-00-00

instr__dividend_date

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

instr__eps

-4.27

instrument_learn_more

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
Markets.com Bonus Trading

related_instruments

Asset
Sell
Buy
Change (%)

trade_now_btn

trade_now_btn

trade_now_btn

trade_now_btn
view_all_instruments

latest_education_articles

Show more
Trustpilot